Research programme: growth arrest specific gene 6 inhibitors - Oxurion
Alternative Names: Gas6 inhibitors research programme - Oxurion; Growth arrest specific gene 6 inhibitors research programme - OxurionLatest Information Update: 11 Sep 2018
At a glance
- Originator University of Leuven
- Developer Thromb-X; ThromboGenics
- Class
- Mechanism of Action Growth arrest-specific protein 6 inhibitors; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 10 Sep 2018 Thrombogenics is now called Oxurion
- 04 Jun 2003 This programme is still in active development
- 22 May 2001 New profile